Insulin Pens Market Analysis and Forecast to 2032: By Product Type (Reusable Insulin Pens, Disposable Insulin Pens), Indication (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics) and Region

An insulin pen is an infusion device used to infuse insulin into diabetic patients. Patients suffering from type 1 diabetes prefer insulin pens for their management. Insulin pen overtures simpler administration of insulin into the body. It provides more precise dosages and less pain compared to vials and syringes and is also preferred by clinicians and patients. Insulin pen supports in improving quality of life and reducing fear of hyperglycemia. The low cost of insulin pens increases their affordability among the g different groups group of people the insulin pens comprise two categories including reusable and disposable insulin pens. A prefilled insulin pen is a disposable pen that is preferred by people for insulin infusion. Insulin pen needles are shorter and thinner than syringes.

 

 

 

 

 

Market Drivers

Increasing prevalence of diabetes worldwide

Diabetes is a chronic disease that occurs either when the pancreas is unable to synthesize enough insulin or when the body cannot effectively use the insulin prepared by it. Insulin is a hormone that regulates blood sugar. Hyperglycaemia is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body’s systems, majorly the nerves and blood vessels. In 2014, 8.5% of adults aged 18 years and older had diabetes. In 2019, diabetes was the direct cause of 1.5 million deaths and 48% of all deaths occurred before the age of 70 years. Between 2000 and 2016, there was a 5% increase in premature mortality rates (i.e., before the age of 70) from diabetes. In high-income economies, the premature mortality rate due to diabetes decreased from 2000 to 2010 but then increased from 2010-to 2016. Likewise, in lower-middle-income economies, premature mortality owing to diabetes raised across both periods.

Market Opportunities

Growing healthcare spending on the treatment of Diabetes

The American Diabetes Association (ADA) released research on March 22, 2018, estimating the total cost of diagnosed diabetes has grown to $327 billion in 2017 from $245 billion in 201 when the cost was last examined. This figure represents a 26% increase over five years The largest components of medical expenditures are: hospital inpatient care (30% of the total medical cost), prescription medications to treat complications of diabetes (30%), anti-diabetic agents and diabetes supplies (15%) and physician office visits (13%). People with diagnosed diabetes incur average medical expenditures of $16,752 per year, of which about $9,601 is attributed to diabetes. On average, people with diagnosed diabetes have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes.

Market Restraints

The stringent regulatory approval process

Pen, jets, and related injectors may be marketed under various provisions. For instance, pen injectors for general use are regulated as class II devices under 21 CFR 880.5860 (Product code NSC) or 21 CFR 880.6920 (product code KZH). Jet injectors for general use, injectors are regulated by CDRH. When injectors are combined with, packaged with, or labeled for use with a specific drug or biological products which may be combination products.

FDA recommends a pre-submission meeting with the lead Centre to discuss how manufacturers propose to organize the NDA/BLA Common Technical Document (CTD) submission to identify the injector-related information. Similar meetings should be requested when an NDA/BLA submission is used along with a separate device submission.

Impact of COVID-19 on Insulin Pens Market

The COVID-19 pandemic remains a global health concern, and those living with chronic medical conditions such as diabetes have been identified as being at higher risk of severe symptoms and complications from the virus and due to that, it has a mixed impact on the insulin pens market. That who have been admitted to the hospital for COVID-19 were also found to have new instances of hyperglycemia or high levels of blood sugar, with some persisting beyond infection. As diabetes is a condition that can happen to anyone regardless of age, it is essential to understand how to properly manage it, particularly when access to healthcare is limited by continuous shutdowns.

Market Segmental Analysis

The insulin pen market is bifurcated into various segments such as product type, indications, and distribution channels.

Insulin Pens Market by Product Type

The various product types comprised in the insulin pens market are reusable insulin pens and disposable insulin pens. The reusable insulin pen segment is also sub-segmented into refillable pens, Bluetooth-connected smart insulin pens, USB-connected smart insulin pens, and cartridges.

The reusable insulin pen is likely to dominate the insulin pen market during the projection period. The factors such different advantages of reusable pens, the most significant benefit comprise durability which assists in removing a barrier of large space required for disposable insulin pens and flexibility in carrying a 3–5-day supply. Meanwhile, the reusable insulin pens are more accurate in terms of fulfilling the dose accuracy according to international standards (ISO-11608-1).

Insulin Pens Market by Indication

The various indications comprised in the insulin pens market are type 1 diabetes and type 2 diabetes.

Type 1 diabetes is expected to dominate the insulin pens market at a constant rate during the forecast period. The rising prevalence of diabetes in the various age groups is an essential factor boosting the growth of the market. Adding to that, increasing R&D activities are also refueling the growth of the market.

Insulin Pens Market by Distribution Channel

The different distribution channels comprised in the insulin pens market is hospital pharmacies, retail pharmacy, online sales, and diabetes clinics.

The diabetes clinics segment is likely to dominate the insulin pens market during the forecast period. The exponentially growing population of diabetic patients is prominently boosting the growth of the insulin pens market. Adding to that, an increase in government expenditure on diabetes is expected to create new technologies and therapies for inhibiting the rapidly rising prevalence of diabetes worldwide.

Regional Analysis of Insulin Pens Market

The insulin pens market is studied for various key countries of regions such as North America, Europe, Asia-Pacific, and the Rest of the World.

North America is expected to dominate the insulin pens market during the projection period owing to the higher prevalence of diabetes as well as higher healthcare spending on the treatment of diabetes. Adding to that, technological advancements in insulin pens are projected to boost the adoption of insulin pens in North America. Europe is anticipated to witness considerable growth due to patients’ gradual shift to self-care instead of dependency. The Asia Pacific is projected to register a comparatively higher growth rate owing to the higher patient pool of diabetic patients. Moreover, the implementation of intense market penetration strategies by major market players is anticipated to lead to increased adoption of insulin pens in the region during the forecast period.

Market Players of Insulin Pens Market

Some of the key players of Insulin Pens Market are B. Braun Melsungen AG (US), Eli Lilly and Company (US), Artsana S.p.A. (US), Becton Dickinson (US), Sanofi (France), Owen Mumford Ltd. (UK), Ypsomed AG (Switzerland), TERUMO CORPORATION (Japan), HTL-Strefa (US), and Biocon (US).

Key Developments in Insulin Pens Market
  • March 2022: Novo Nordisk launched the first smart insulin pens for NHS patients. Its smart insulin pens are available in the UK, giving people treated within the NHS diabetes access to devices that can monitor and record dosing information for the first time.
  • September 2021: Novo Nordisk smarten up its disposable insulin pens with digital diabetes device maker Biocorp.
  • May 2021: Eli Lily and Company signed a strategic international agreement with four companies- DexCom, Inc., Glooko Inc., myDiabby Healthcare, and Roche- to advance connected solutions and streamline care for people living with diabetes in the market outside the United States. These companies offer unique diabetes management platforms which will be compatible with Lilly’s Tempo Pen and Tempo Smart Button to support people with diabetes and healthcare professionals.
Market Segmentation

The Insulin Pens Market is segmented into Product Type, Indication, Distribution Channel, and Region. On the basis of Product Type, the Insulin Pens Market is segmented into Reusable Insulin Pen, and Disposable Insulin Pens. Based on Indication, the market is bifurcated into Type 1 Diabetes and Type 2 Diabetes. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Sales, and Diabetes Clinics. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and Rest of the World.

Insulin Pens Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current Insulin Pens Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.    
  • The report also covers qualitative as well as quantitative analysis of Insulin Pens Market in terms of revenue ($Million).    
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Insulin Pens industry.
  • A thorough analysis of market trends and restraints is provided.    
  • By region as well as country market analysis is also presented in this report.    
  • Analytical depiction of the Insulin Pens Market along with the current trends and future estimations to depict imminent investment pockets. The overall Insulin Pens industry opportunity is examined by understanding profitable trends to gain a stronger foothold.    
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Insulin Pens Market are also analyzed.Why GIS?
Table of Contents

Chapter 1.Insulin Pens Market Overview
1.1.Objectives of the Study
1.2.Market Definition and Research & Scope
1.3.Research Limitations
1.4.Research Methodologies
1.4.1.Secondary Research
1.4.2.Market Size Estimation Technique
1.4.3.Forecasting
1.4.4.Primary Research and Data Validation

Chapter 2.Executive Summary
2.1.Summary
2.2.Key Highlights of the Market

Chapter 3.Premium Insights on the Market
3.1.Market Attractiveness Analysis, by Region
3.2.Market Attractiveness Analysis, by Product Type
3.3.Market Attractiveness Analysis, by Indication
3.4.Market Attractiveness Analysis, by Distribution Channel

Chapter 4.Insulin Pens Market Outlook
4.1.Insulin Pens Market Segmentation
4.2.Market Dynamics
4.2.1.Market Drivers
4.2.1.1.Driver 1
4.2.1.2.Driver 2
4.2.1.3.Driver 3
4.2.2.Market Restraints
4.2.2.1.Restraint 1
4.2.2.2.Restraint 2
4.2.3.Market Opportunities
4.2.3.1.Opportunity 1
4.2.3.2.Opportunity 2
4.3.Porter’s Five Forces Analysis
4.3.1.Threat of New Entrants
4.3.2.Threat of Substitutes
4.3.3.Bargaining Power of Buyers
4.3.4.Bargaining Power of Supplier
4.3.5.Competitive Rivalry
4.4.PESTLE Analysis
4.5.Value Chain Analysis
4.5.1.Raw Material Suppliers
4.5.2.Manufacturers
4.5.3.Wholesalers and/or Retailers
4.6.Impact of COVID-19 on the Insulin Pens Market
4.7.Impact of the Russia and Ukraine War on the Insulin Pens Market
4.8.Case Study Analysis
4.9.Pricing Analysis

Chapter 5.Insulin Pens Market, by Product Type
5.1.Market Overview
5.2.Reusable Insulin Pen
5.2.1.Key Market Trends & Opportunity Analysis
5.2.2.Market Size and Forecast, by Region
5.3.Disposable Insulin Pens
5.3.1.Key Market Trends & Opportunity Analysis
5.3.2.Market Size and Forecast, by Region

Chapter 6.Insulin Pens Market, by Indication
6.1.Market Overview
6.2.Type 1 Diabetes
6.2.1.Key Market Trends & Opportunity Analysis
6.2.2.Market Size and Forecast, by Region
6.3.Type 2 Diabetes
6.3.1.Key Market Trends & Opportunity Analysis
6.3.2.Market Size and Forecast, by Region

Chapter 7.Insulin Pens Market, by Distribution Channel
7.1.Market Overview
7.2.Hospital Pharmacy
7.2.1.Key Market Trends & Opportunity Analysis
7.2.2.Market Size and Forecast, by Region
7.3.Retail Pharmacy
7.3.1.Key Market Trends & Opportunity Analysis
7.3.2.Market Size and Forecast, by Region
7.4.Online Sales
7.4.1.Key Market Trends & Opportunity Analysis
7.4.2.Market Size and Forecast, by Region
7.5.Diabetes Clinics
7.5.1.Key Market Trends & Opportunity Analysis
7.5.2.Market Size and Forecast, by Region

Chapter 8.Insulin Pens Market, by Region
8.1.Overview
8.2.North America
8.2.1.Key Market Trends and Opportunities
8.2.2.North America Insulin Pens Market Size and Forecast, by Product Type
8.2.3.North America Insulin Pens Market Size and Forecast, by Distribution Channel
8.2.4.North America Insulin Pens Market Size and Forecast, by Indication
8.2.5.North America Insulin Pens Market Size and Forecast, by Country
8.2.6.The U.S.
8.2.6.1.The U.S. Insulin Pens Market Size and Forecast, by Product Type
8.2.6.2.The U.S. Insulin Pens Market Size and Forecast, by Distribution Channel
8.2.6.3.The U.S. Insulin Pens Market Size and Forecast, by Indication
8.2.7.Canada
8.2.7.1.Canada Insulin Pens Market Size and Forecast, by Product Type
8.2.7.2.Canada Insulin Pens Market Size and Forecast, by Distribution Channel
8.2.7.3.Canada Insulin Pens Market Size and Forecast, by Indication
8.2.8.Mexico
8.2.8.1.Mexico Insulin Pens Market Size and Forecast, by Product Type
8.2.8.2.Mexico Insulin Pens Market Size and Forecast, by Distribution Channel
8.2.8.3.Mexico Insulin Pens Market Size and Forecast, by Indication
8.3.Europe
8.3.1.Key Market Trends and Opportunities
8.3.2.Europe Insulin Pens Market Size and Forecast, by Product Type
8.3.3.Europe Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.4.Europe Insulin Pens Market Size and Forecast, by Indication
8.3.5.Europe Insulin Pens Market Size and Forecast, by Country
8.3.6.The U.K.
8.3.6.1.The U.K. Insulin Pens Market Size and Forecast, by Product Type
8.3.6.2.The U.K. Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.6.3.The U.K. Insulin Pens Market Size and Forecast, by Indication
8.3.7.Germany
8.3.7.1.Germany Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.7.2.Germany Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.7.3.Germany Insulin Pens Market Size and Forecast, by Indication
8.3.8.France
8.3.8.1.France Insulin Pens Market Size and Forecast, by Product Type
8.3.8.2.France Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.8.3.France Insulin Pens Market Size and Forecast, by Indication
8.3.9.Spain
8.3.9.1.Spain Insulin Pens Market Size and Forecast, by Product Type
8.3.9.2.Spain Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.9.3.Spain Insulin Pens Market Size and Forecast, by Indication
8.3.10.Italy
8.3.10.1.Italy Insulin Pens Market Size and Forecast, by Product Type
8.3.10.2.Italy Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.10.3.Italy Insulin Pens Market Size and Forecast, by Indication
8.3.11. Netherlands
8.3.11.1.Netherlands Insulin Pens Market Size and Forecast, by Product Type
8.3.11.2.Netherlands Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.11.3.Netherlands Insulin Pens Market Size and Forecast, by Indication
8.3.12. Sweden
8.3.12.1.Sweden Insulin Pens Market Size and Forecast, by Product Type
8.3.12.2.Sweden Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.12.3.Sweden Insulin Pens Market Size and Forecast, by Indication
8.3.13.Switzerland
8.3.13.1.Switzerland Insulin Pens Market Size and Forecast, by Product Type
8.3.13.2.Switzerland Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.13.3.Switzerland Insulin Pens Market Size and Forecast, by Indication
8.3.14.Denmark
8.3.14.1.Denmark Insulin Pens Market Size and Forecast, by Product Type
8.3.14.2.Denmark Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.14.3.Denmark Insulin Pens Market Size and Forecast, by Indication
8.3.15.Finland
8.3.15.1.Finland Insulin Pens Market Size and Forecast, by Product Type
8.3.15.2.Finland Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.15.3.Finland Insulin Pens Market Size and Forecast, by Indication
8.3.16.Russia
8.3.16.1.Russia Insulin Pens Market Size and Forecast, by Product Type
8.3.16.2.Russia Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.16.3.Russia Insulin Pens Market Size and Forecast, by Indication
8.3.17.Rest of Europe
8.3.17.1.Rest of Europe Insulin Pens Market Size and Forecast, by Product Type
8.3.17.2.Rest of Europe Insulin Pens Market Size and Forecast, by Distribution Channel
8.3.17.3.Rest of Europe Insulin Pens Market Size and Forecast, by Indication
8.4.Asia-Pacific
8.4.1.Key Market Trends and Opportunities
8.4.2.Asia-Pacific Insulin Pens Market Size and Forecast, by Country
8.4.3.Asia-Pacific Insulin Pens Market Size and Forecast, by Product Type
8.4.4.Asia-Pacific Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.5.Asia-Pacific Insulin Pens Market Size and Forecast, by Indication
8.4.6.China
8.4.6.1.China Insulin Pens Market Size and Forecast, by Product Type
8.4.6.2.China Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.6.3.China Insulin Pens Market Size and Forecast, by Indication
8.4.7.India
8.4.7.1.India Insulin Pens Market Size and Forecast, by Product Type
8.4.7.2.India Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.7.3.India Insulin Pens Market Size and Forecast, by Indication
8.4.8.Japan
8.4.8.1.Japan Insulin Pens Market Size and Forecast, by Product Type
8.4.8.2.Japan Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.8.3.Japan Insulin Pens Market Size and Forecast, by Indication
8.4.9.South Korea
8.4.9.1.South Korea Insulin Pens Market Size and Forecast, by Product Type
8.4.9.2.South Korea Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.9.3.South Korea Insulin Pens Market Size and Forecast, by Indication
8.4.10. Australia
8.4.10.1.Australia Insulin Pens Market Size and Forecast, by Product Type
8.4.10.2.Australia Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.10.3.Australia Insulin Pens Market Size and Forecast, by Indication
8.4.11.Singapore
8.4.11.1.Singapore Insulin Pens Market Size and Forecast, by Product Type
8.4.11.2.Singapore Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.11.3.Singapore Insulin Pens Market Size and Forecast, by Indication
8.4.12.Indonesia
8.4.12.1.Indonesia Insulin Pens Market Size and Forecast, by Product Type
8.4.12.2.Indonesia Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.12.3.Indonesia Insulin Pens Market Size and Forecast, by Indication
8.4.13.Taiwan
8.4.13.1.Taiwan Insulin Pens Market Size and Forecast, by Product Type
8.4.13.2.Taiwan Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.13.3.Taiwan Insulin Pens Market Size and Forecast, by Indication
8.4.14.Malaysia
8.4.14.1.Malaysia Insulin Pens Market Size and Forecast, by Product Type
8.4.14.2.Malaysia Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.14.3.Malaysia Insulin Pens Market Size and Forecast, by Indication
8.4.15.Rest of APAC
8.4.15.1.Rest of APAC Insulin Pens Market Size and Forecast, by Product Type
8.4.15.2.Rest of APAC Insulin Pens Market Size and Forecast, by Distribution Channel
8.4.15.3.Rest of APAC Insulin Pens Market Size and Forecast, by Indication
8.5.Rest of The World
8.5.1.Key Market Trends and Opportunities
8.5.2.Rest of The World Insulin Pens Market Size and Forecast, by Product Type
8.5.3.Rest of The World Insulin Pens Market Size and Forecast, by Distribution Channel
8.5.4.Rest of The World Insulin Pens Market Size and Forecast, by Indication
8.5.5.Rest of The World Insulin Pens Market Size and Forecast, by Country
8.5.6.Latin America
8.5.6.1.Latin America Insulin Pens Market Size and Forecast, by Product Type
8.5.6.2.Latin America Insulin Pens Market Size and Forecast, by Distribution Channel
8.5.6.3.Latin America Insulin Pens Market Size and Forecast, by Indication
8.5.7.Middle East
8.5.7.1.Middle East Insulin Pens Market Size and Forecast, by Product Type
8.5.7.2.Middle East Insulin Pens Market Size and Forecast, by Distribution Channel
8.5.7.3.Middle East Insulin Pens Market Size and Forecast, by Indication
8.5.8.Africa
8.5.8.1.Africa Insulin Pens Market Size and Forecast, by Product Type
8.5.8.2.Africa Insulin Pens Market Size and Forecast, by Distribution Channel
8.5.8.3.Africa Insulin Pens Market Size and Forecast, by Indication

Chapter 9.Competitive Landscape
9.1.Market Overview
9.2.Market Share Analysis/Key Player Positioning
9.3.Developmental Strategy Benchmarking
9.3.1.New Product Development
9.3.2.Product Launches
9.3.3.Business Expansions
9.3.4.Partnerships, Joint Ventures, And Collaborations
9.3.5.Mergers And Acquisitions

Chapter 10.Company Profiles
10.1.B. Braun Melsungen AG (US)
10.1.1.Company Snapshot
10.1.2.Financial Performance
10.1.3.Product Offerings
10.1.4.Key Strategic Initiatives
10.1.5.SWOT Analysis
10.2.Eli Lilly and Company (US)
10.2.1.Company Snapshot
10.2.2.Financial Performance
10.2.3.Product Offerings
10.2.4.Key Strategic Initiatives
10.2.5.SWOT Analysis
10.3.Artsana S.p.A. (US)
10.3.1.Company Snapshot
10.3.2.Financial Performance
10.3.3.Product Offerings
10.3.4.Key Strategic Initiatives
10.3.5.SWOT Analysis
10.4.Becton Dickinson (US)
10.4.1.Company Snapshot
10.4.2.Financial Performance
10.4.3.Product Offerings
10.4.4.Key Strategic Initiatives
10.4.5.SWOT Analysis
10.5.Sanofi (France)
10.5.1.Company Snapshot
10.5.2.Financial Performance
10.5.3.Product Offerings
10.5.4.Key Strategic Initiatives
10.5.5.SWOT Analysis
10.6.Owen Mumford Ltd. (UK)
10.6.1.Company Snapshot
10.6.2.Financial Performance
10.6.3.Product Offerings
10.6.4.Key Strategic Initiatives
10.6.5.SWOT Analysis
10.7.Ypsomed AG (Switzerland)
10.7.1.Company Snapshot
10.7.2.Financial Performance
10.7.3.Product Offerings
10.7.4.Key Strategic Initiatives
10.7.5.SWOT Analysis
10.8.TERUMO CORPORATION (Japan)
10.8.1.Company Snapshot
10.8.2.Financial Performance
10.8.3.Product Offerings
10.8.4.Key Strategic Initiatives
10.8.5.SWOT Analysis
10.9.HTL-Strefa (US)
10.9.1.Company Snapshot
10.9.2.Financial Performance
10.9.3.Product Offerings
10.9.4.Key Strategic Initiatives
10.9.5.SWOT Analysis
10.10.Biocon (US)
10.10.1.Company Snapshot
10.10.2.Financial Performance
10.10.3.Product Offerings
10.10.4.Key Strategic Initiatives
10.10.5.SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report

Key Players
Market Segments

By Product Type

  • Reusable Insulin Pen
  • Disposable Insulin Pens

By Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics

By Region

  • North America  
    • The U.S. 
    • Canada 
    • Mexico 
  • Europe 
    • The U.K. 
    • Germany 
    • France 
    • Spain 
    • Italy 
    • Netherlands 
    • Sweden 
    • Switzerland 
    • Denmark 
    • Finland 
    • Russia 
    • Rest of Europe 
  • The Asia-Pacific 
    • China 
    • India 
    • Japan 
    • South Korea 
    • Australia 
    • Singapore 
    • Indonesia 
    • Taiwan 
    • Malaysia 
    • Rest of Asia-Pacific 
  • Rest of the World 
    • Latin America 
    • The Middle East 
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global companion diagnostics market was valued at…
The global soft tissue anchors market was valued…
The global protein A resin market was valued…
The global minimally invasive surgical instruments market was…
Corneal topographers are devices used to measure the…
Cardiac autonomic control is the regulation of the…
HbA1c laboratory testing is a type of blood…
The global nuclear imaging equipment market size was…
Vial Box is a new type of container…
PEEK implants are synthetic implants that are used…